These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 8105865)

  • 1. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
    Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
    Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cells.
    Schuurhuis GJ; Broxterman HJ; Cervantes A; van Heijningen TH; de Lange JH; Baak JP; Pinedo HM; Lankelma J
    J Natl Cancer Inst; 1989 Dec; 81(24):1887-92. PubMed ID: 2574239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
    Coley HM; Amos WB; Twentyman PR; Workman P
    Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
    Schuurhuis GJ; Broxterman HJ; de Lange JH; Pinedo HM; van Heijningen TH; Kuiper CM; Scheffer GL; Scheper RJ; van Kalken CK; Baak JP
    Br J Cancer; 1991 Nov; 64(5):857-61. PubMed ID: 1681887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells.
    Keizer HG; Schuurhuis GJ; Broxterman HJ; Lankelma J; Schoonen WG; van Rijn J; Pinedo HM; Joenje H
    Cancer Res; 1989 Jun; 49(11):2988-93. PubMed ID: 2566376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
    Rhodes T; Barrand MA; Twentyman PR
    Br J Cancer; 1994 Jul; 70(1):60-6. PubMed ID: 7912544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of ABC-transporter(s)' function in non-small cell lung cancer cells by platinum drugs].
    Bogush TA; Konukhova AV; Ravcheeva AB; Zabotina TN; Kadagidze ZG; Bogush EA; Komov DV; Polotskiĭ BE; Laktionov KK; Davydov MI
    Antibiot Khimioter; 2003; 48(10):11-5. PubMed ID: 15004974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line.
    Bennis S; Ichas F; Robert J
    Int J Cancer; 1995 Jul; 62(3):283-90. PubMed ID: 7628869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil.
    Keizer HG; Joenje H
    J Natl Cancer Inst; 1989 May; 81(9):706-9. PubMed ID: 2565404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines.
    Huet S; Schott B; Robert J
    Br J Cancer; 1992 Apr; 65(4):538-44. PubMed ID: 1348623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.
    Nygren P; Larsson R; Gruber A; Peterson C; Bergh J
    Br J Cancer; 1991 Dec; 64(6):1011-8. PubMed ID: 1684906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
    Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
    J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
    Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin.
    Sadasivan R; Morgan R; Fabian C; Stephens R
    Cancer Lett; 1991 May; 57(2):165-71. PubMed ID: 1673873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific.
    Plumb JA; Milroy R; Kaye SB
    Biochem Pharmacol; 1990 Feb; 39(4):787-92. PubMed ID: 1968341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of multiple drug resistance in human bladder cancer cell lines.
    Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB
    J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.